A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study

Autor: Bugarski-Kirola, D., Wang, A., Abi-Saab, D., Blättler, T.
Zdroj: In European Neuropsychopharmacology July 2014 24(7):1024-1036
Databáze: ScienceDirect